MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway

BACKGROUND: Osteosarcoma is the most prevalent primary malignant bone tumor containing mesenchymal cells with poor prognosis. Being a hot spot of anti-tumor therapy researches, AKT/mammalian target of rapamycin (mTOR) signaling pathway could affect various cellular processes including transcription,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Dong, Ge, Shanshan, Li, Mengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842083/
https://www.ncbi.nlm.nih.gov/pubmed/35198364
http://dx.doi.org/10.1016/j.jbo.2022.100412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842083/
https://www.ncbi.nlm.nih.gov/pubmed/35198364
http://dx.doi.org/10.1016/j.jbo.2022.100412

Ejemplares similares